Neurology Minute

American Academy of Neurology
undefined
Jun 24, 2025 • 2min

Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 2

In the second installment of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss clinical guidance for managing patients who may experience neurotoxicity from CAR T-cell, with a specific focus on seizure risk. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213535
undefined
Jun 23, 2025 • 3min

June 2025 President Spotlight: Advocacy in Neurology

In the June episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss advocacy opportunities. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
undefined
Jun 20, 2025 • 2min

Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 1

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss the incidence of acute symptomatic seizures during CAR T-cell therapy. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213535
undefined
Jun 19, 2025 • 2min

Electronic Medical Record Alert to Prevent Iatrogenic Interventions in Patients With PNES

Dr. Halley Alexander and Dr. Serena Yin discuss the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of PNES. Show references: https://www.neurology.org/doi/10.1212/CPJ.0000000000200457
undefined
Jun 18, 2025 • 2min

June 2025 Capitol Hill Report

In the first episode of this new series, Dr. Andy Southerland discusses the June updates from the AAN's Capitol Hill Report (CHR). This month's CHR update includes a member story from Dr. José Posas. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
undefined
Jun 17, 2025 • 2min

Inebilizumab in Generalized Myasthenia Gravis

Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
undefined
Jun 16, 2025 • 3min

Optic Nerve Imaging - Part 3

In the final installment of this three-part series, Dr. Elizabeth Zollos discusses another important diagnostic tool, visually evoked potentials or VEP.
undefined
Jun 13, 2025 • 3min

Patient Perspectives on Antiseizure Medication Discontinuation

Dr. Halley Alexander and Dr. Samuel W. Terman discuss patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200475
undefined
Jun 12, 2025 • 3min

Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge

Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213638
undefined
Jun 11, 2025 • 1min

Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 3

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss his team's findings on the treatment approach presented in this paper. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app